This Thermo Fisher Scientific Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - AeroVironment ( NASDAQ:AVAV ) , Celestica ( NYSE:CLS )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Nuvalent ( NUVL ) Q2 R&D Up 65%
Nuvalent ( NASDAQ:NUVL ) , a clinical-stage biotechnology company developing therapies for cancers driven by kinase mutations, released its second quarter 2025 earnings results on August 7, 2025. There was no product revenue, consistent with expectations for a pre-commercial biotech.
Nuvalent Touts 'Positive' Data From Lung Cancer Drug Trial - Nuvalent ( NASDAQ:NUVL )
Zidesamtinib achieves a 51% ORR and 93% 12- and 18-month durability in patients with one prior ROS1 TKI. Intracranial ORR is 85% in patients previously treated with crizotinib, including 54% complete responses.
Climb Bio Appoints Perrin Wilson, Ph.D., as Chief Business Officer
WELLESLEY HILLS, Mass., Feb. 24, 2025 ( GLOBE NEWSWIRE ) -- Climb Bio, Inc. ( Nasdaq: CLYM ) announced today the appointment of Perrin Wilson, Ph.D. as Chief Business Officer. Dr. Wilson is an accomplished leader, with over 17 years of experience in the pharmaceutical and biotech industry.
Climb Bio Appoints Perrin Wilson, Ph.D., as Chief Business Officer - Climb Bio ( NASDAQ:CLYM )
WELLESLEY HILLS, Mass., Feb. 24, 2025 ( GLOBE NEWSWIRE ) -- Climb Bio, Inc. CLYM announced today the appointment of Perrin Wilson, Ph.D. as Chief Business Officer. Dr. Wilson is an accomplished leader, with over 17 years of experience in the pharmaceutical and biotech industry.
This Nuvalent Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Arcutis Biotherapeutics ( NASDAQ:ARQT ) , Artiva Biotherapeutics ( NASDAQ:ARTV )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. HC Wainwright & Co. analyst Ed Arce initiated coverage on MetaVia MTVA with a Buy rating and announced a ...
Biotech Stock Roundup: GILD, NUVL Stocks Surge on Study Data, MRNA Down on Updates
Gilead Sciences and Nuvalent are in the spotlight following positive updates on key candidates.
Nuvalent Stock Moves Up 20% in a Week: What's Driving the Rally?
The upside comes after NUVL reported encouraging data on two experimental lung cancer therapies.
Why Nuvalent ( NUVL ) Shares Are Down 6% Today - Nuvalent ( NASDAQ:NUVL )
Nuvalent Inc NUVL shares are trading lower by 6.56% to $104.81 during Tuesday's session after the company priced a $500 million upsized public offering of 5 million common shares at $100 per share. Nuvalent says the offering is expected to close on September 18, pending the satisfaction of ...
Company News for Sep 17, 2024
Companies In The News Are: INTC, BA, NUVL, AA.
Nuvalent Stock Jumps On ESMO Data Presentation, Seeks To Raise $350M Via Equity - Nuvalent ( NASDAQ:NUVL )
Over the weekend, Nuvalent, Inc. NUVL highlighted the presentation of updated data from Phase 1 dose-escalation portions of the ongoing ARROS-1 Phase 1/2 trial of zidesamtinib and ALKOVE-1 Phase 1/2 trial of NVL-655, at the European Society for Medical Oncology ( ESMO ) Congress 2024.
Crude Oil Surges Over 1%; Instil Bio Shares Plunge - NuCana ( NASDAQ:NCNA )
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling around 1% on Monday. The Dow traded up 0.29% to 41,512.19 while the NASDAQ fell 0.96% to 17,514.54. The S&P 500 also fell, dropping, 0.24% to 5,612.35. In trading on Monday, information technology shares fell by ...
Alcoa, Lattice Semiconductor, Stratasys And Other Big Stocks Moving Higher On Monday - Alcoa ( NYSE:AA )
U.S. stocks were mixed, with the Dow Jones index gaining around 200 points on Monday. Shares of Alcoa Corporation AA rose sharply during Monday's session after the company agreed to sell its 25.1% joint venture stake in Ma'aden for $1.1 billion, including $950 million in Ma'aden shares.
3 Short-Squeeze Stocks Poised for a Jaw-Dropping Rally
Generally, when the masses - including the market's heavy hitters - decide to bet against a security, it's best to avoid it. However, the unique nuances involved with shorting a company opens the door for the contrarian trade. To be sure, so-called short-squeeze stocks to buy are incredibly risky.
Nuvalent Earns Relative Strength Rating Upgrade; Hits Key Benchmark
Nuvalent Earns Relative Strength Rating Upgrade. Hits Key Benchmark Investor's Business Daily ...
Nuvalent Earns Relative Strength Rating Upgrade; Hits Key Threshold
Nuvalent Earns Relative Strength Rating Upgrade. Hits Key Threshold Investor's Business Daily ...
Why Earnings Season Could Be Great for Nuvalent ( NUVL )
Nuvalent (NUVL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
ARS Pharmaceuticals, Nuvalent, and More Stocks See Action From Activist Investors
These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings.
Nuvalent Initiates the Phase 2 Portion of ALKOVE-1 Clinical Trial for Patients with ALK-Positive NSCLC and other Solid Tumors
Nuvalent Initiates the Phase 2 Portion of ALKOVE-1 Clinical Trial for Patients with ALK-Positive NSCLC and other Solid ... PR ...
Nuvalent Announces "OnTarget 2026" Operating Plan and Key Anticipated Milestones
Targeting first approved product in 2026 towards realizing mission of bringing new, potential best-in-class treatments to patients with cancer Well-capitalized to support OnTarget 2026 initiatives with operating runway anticipated into 2027 Company to present at 42nd Annual J.P.
Why Nuvalent Stock Tanked on Tuesday
The dilution monster stalked the company following the announcement of a new capital-raising effort.
Nuvalent Announces Public Offering of Common Stock
CAMBRIDGE, Mass., Oct. 16, 2023 /PRNewswire/ -- Nuvalent, Inc. ( Nasdaq: NUVL ) , a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that it has commenced an underwritten public offering of ...
's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet - A10 Networks ( NYSE:ATEN ) , American Airlines Group ( NASDAQ:AAL )
Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance to uncover new information.
Why Nuvalent Stock Skyrocketed 35% This Week
Nuvalent announced favorable preliminary data in a clinical trial for its lung cancer drug. Here's what investors need to know.
Nuvalent ( NUVL ) Soars 36% on Upbeat Initial NSCLC Study Data
Nuvalent (NUVL) surges 36% on encouraging preliminary results from the phase I dose-escalation portion of its early-mid-stage development program for NVL-655 to treat advanced ALK-positive NSCLC.
Why Nuvalent Stock Was Soaring Wednesday
The company reported preliminary data on a non-small cell lung cancer therapy.
Preliminary Phase 1 Dose-Escalation Data from ALKOVE-1 Trial of NVL-655 Demonstrated Activity in Heavily Pre-Treated Patients with ALK-Positive NSCLC and an ALK-Selective, TRK-Sparing Safety Profile
Preliminary Phase 1 Dose-Escalation Data from ALKOVE-1 Trial of NVL-655 Demonstrated Activity in Heavily Pre ... PR ...
Challenging Road Ahead for Cancer Drugs, Nuvalent Seeks to Break the Mold - Nuvalent ( NASDAQ:NUVL )
Stifel initiated coverage on Nuvalent Inc NUVL, recognizing that adopting a bullish stance in anticipation of Phase 1 cancer drug data, mainly when derived from heavily pretreated patients, has proven unprofitable for approximately two years. The analyst keeps the price target of $65, with a Buy ...
Canopy Growth, DocGo And Other Big Stocks Moving Lower On Monday - AMC Enter Hldgs ( NYSE:AMC ) , ARM Holdings ( NASDAQ:ARM )
U.S. stocks traded mostly flat on Monday. Here are some big stocks recording losses in today's session. Scilex Holding Company SCLX shares dipped 17.3% to $1.86. Scilex recently announced the completion of its SP-103 Phase 2 study to evaluate the safety and efficacy in subjects with acute LBP.
Recent Price Trend in Nuvalent, Inc. ( NUVL ) is Your Friend, Here's Why
If you are looking for stocks that are well positioned to maintain their recent uptrend, Nuvalent, Inc. (NUVL) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Nuvalent, Inc. ( NUVL ) Is a Great Choice for 'Trend' Investors, Here's Why
Nuvalent, Inc. (NUVL) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Nuvalent Highlights Pipeline and Business Progress and Reports Fourth Quarter and Full Year 2022 Financial Results
Nuvalent Highlights Pipeline and Business Progress and Reports ... PR ...
Are Medical Stocks Lagging DICE Therapeutics ( DICE ) This Year?
Here is how DICE Therapeutics, Inc. (DICE) and Nuvalent, Inc. (NUVL) have performed compared to their sector so far this year.
Here's Why Momentum in Nuvalent, Inc. ( NUVL ) Should Keep going
Nuvalent, Inc. (NUVL) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
What Makes Nuvalent, Inc. ( NUVL ) a Strong Momentum Stock: Buy Now?
Does Nuvalent, Inc. (NUVL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is Genmab ( GMAB ) Outperforming Other Medical Stocks This Year?
Here is how Genmab AS Sponsored ADR (GMAB) and Nuvalent, Inc. (NUVL) have performed compared to their sector so far this year.
$21.8 Million Bet On Nuvalent? 4 Stocks Insiders Are Buying - Global Payments ( NYSE:GPN ) , Nuvalent ( NASDAQ:NUVL )
Although US stocks closed higher on Monday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock.
$7.8 Million Bet On Appian? 4 Stocks Insiders Are Buying - Appian ( NASDAQ:APPN ) , AptarGroup ( NYSE:ATR )
Although US stocks closed lower on Thursday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock.
Nuvalent Director Makes $5.00M Stock Purchase - Nuvalent ( NASDAQ:NUVL )
Andrew A. F. Hack, Director at Nuvalent NUVL, reported a large insider buy on November 3, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that Hack purchased 149,253 shares of Nuvalent.
TuSimple, Y-mAbs Therapeutics And Some Other Big Stocks Moving Lower In Today's Pre-Market Session - Nuvalent ( NASDAQ:NUVL ) , Hanesbrands ( NYSE:HBI )
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today's pre-market trading session. Y-mAbs Therapeutics, Inc.
Nuvalent Announces Public Offering of Common Stock
CAMBRIDGE, Mass., Oct. 31, 2022 /PRNewswire/ -- Nuvalent, Inc. ( Nasdaq: NUVL ) , a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that it has commenced an underwritten public offering of ...
Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday - Aeglea BioTherapeutics ( NASDAQ:AGLE ) , Avista Public Acquisition ( NASDAQ:AHPA )
Quanergy Systems, Inc. QNGY jumped 153.9% to close at $3.30 on Friday. Aeglea BioTherapeutics, Inc. AGLE surged 61.4% to close at $0.92 after jumping 15% on Thursday. Nuvalent, Inc.
Nasdaq Climbs 275 Points; S&P 500 Rises Over 2% - Chevron ( NYSE:CVX ) , Alpine 4 Holdings ( NASDAQ:ALPP )
U.S. stocks extended gains toward the end of trading, with the Nasdaq Composite surging more than 200 points on Friday. The Dow traded up 2.44% to 32,814.96 while the NASDAQ rose 2.56% to 11,068.96. The S&P 500 also rose, gaining, 2.24% to 3,892.40. Also check this: Bitcoin Jumps Above 20,000.
This IPO Stock Is Flirting With A Record High On A Tricky Cancer Win
Recent IPO stock Nuvalent Therapeutics ( NUVL ) surged within striking distance of a record high Friday on promising test results in lung cancer.
Dow Jumps 600 Points; Crude Oil Down Over 1% - Data I/O ( NASDAQ:DAIO ) , DaVita ( NYSE:DVA )
U.S. stocks extended gains midway through trading, with the Dow Jones surging more than 600 points on Friday. The Dow traded up 1.92% to 32,648.16 while the NASDAQ rose 1.74% to 10,979.98. The S&P 500 also rose, gaining, 1.60% to 3,868.26. Also check this: Bitcoin Jumps Above 20,000.
Why Nuvalent ( NUVL ) Shares Are Soaring Today - Nuvalent ( NASDAQ:NUVL )
Nuvalent Inc NUVL announced the initial data from the Phase 1 dose-escalation portion of its ongoing ARROS-1 Phase 1/2 clinical trial of NVL-520 in advanced ROS1-positive non-small cell lung cancer ( NSCLC ) and other solid tumors.
Apple, Intel, And Some Other Big Stocks Moving Higher On Friday - Apple ( NASDAQ:AAPL ) , AppFolio ( NASDAQ:APPF )
U.S. stocks traded higher, with the Dow Jones gaining more than 500 points on Friday. Here are some big stocks recording gains in today's session. Nuvalent, Inc.
US Stocks Mostly Higher; Dow Surges 300 Points - Cohu ( NASDAQ:COHU ) , Data I/O ( NASDAQ:DAIO )
U.S. stocks traded mostly higher this morning, with the Dow Jones surging more than 300 points on Friday. Following the market opening Friday, the Dow traded up 1.01% to 32,355.66 while the NASDAQ rose 0.06% to 10,799.69. The S&P 500 also rose, gaining, 0.33% to 3,819.94.
This Communication Services Stock Jumped 149%; Here Are 90 Biggest Movers From Friday
Getty Images Holdings, Inc. GETY shares climbed 149.1% to close at $26.15 on Friday following its merger with special-purpose acquisition company ( SPAC ) CC Neuberger Principal Holdings ( CCNB ) . Brookline Capital Acquisition Corp. BCAC gained 127.3% to settle at $22.71. AMTD Digital ...
Stocks That Hit 52-Week Lows On Monday
On Monday, 198 companies reached new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: BlackRock ( NYSE:BLK ) was the largest firm by market cap to set a new 52-week low. The smallest company by market cap to set a new 52-week low was Vallon Pharmaceuticals ( NASDAQ:VLON ) . Chimerix (
